|
|
|
 |
|||
|
|
|
Trials National Marrow Donor Program (NMDP) Protocol for a Research Sample Repository for allogeneic unrelated hematopoietic stem cell transplantation (PCH 05-022) Phase : Registry Site: Phoenix Status: Open National Marrow Donor Program (NMDP) Research Database for unrelated donor transplant (PCH 05-023) Phase : Registry Site: Phoenix Status: Open High dose temozolomide, thiotepa and carboplatin with autologous stem cell rescue (ASCR) followed by continuation therapy with 13-cis-retinoic acid in patients with recurrent/refractory malignant brain tumors (PBMTC ONC-032P) Phase : II Site: Phoenix Status: Open A Study of Hematopoietic Stem Cell Transplantation (HSCT) in Non-Malignant Disease using a Reduced-Intensity preparatory regime with Campath-1H, Fludarabine and Melphalan (PCH 06-046) Phase : I/II Site: Phoenix Status: Open A Randomized Trial of Sirolimus-Based Graft versus Host Disease (GVHD) Prophylaxis after Hematopoietic Stem Cell Transplantation (HSCT) in Relapsed Acute Lymphoblastic Leukemia (ALL) (ASCT0431) Phase : III Site: Phoenix Status: Open Intergoup Randomized Study of Chimeric Anti GD2 in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue (ANBL0032) Phase : III Site: Phoenix Status: Open Fludarabine-based Conditioning for Allogeneic Marrow Transplantation from HLA-compatible Unrelated Donors in Severe Aplastic Anemia (CTN-0301) Phase : I/II Site: Phoenix Status: Open Using the Transcriptome for Early Detection of Graft Versus Host Disease (PCH 07-051) Phase : Biology Site: Phoenix Status: Open Killer Immunoglobulin-like Receptor (KIR) Incompatible Unrelated Donor Hematopoietic Cell Transplantation (HCT) for refractory and Relapsed Acute Myelogenous Leukemia and Newly Diagnosed AML with Monosomy 7 or -5/5q- in Children: A Children's Oncology Group Study (AAML05P1) Phase : Pilot Site: Phoenix Status: Open Defibrotide for Hematopoietic Stem Cell Transplant (SCT) Patient with Severe Hepatic Veno-Occlusive Disease (VOD) : A Treatment IND Study (Under CFR 312.34) Phase : Expanded Access Site: Phoenix Status: Open Multi-center, Open Label, Randomized Trial Comparing Single vs. Double Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients with High Risk Leukemia and Myelodysplasia (CTN 0501) Phase : III Site: Phoenix Status: Open Evaluation of Immune Function following Targeted Receptor Combination Therapy in the Treatment of Steroid-resistant acute Graft vs. Host Disease (PCH 08-043) Phase : Biology Site: Phoenix Status: Open Treatment Protocol to Evaluate Safety and Treatment Outcomes of Prochymal™ (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) Infusion for the Treatment of Steroid-Refractory Acute GVHD in Pediatric Patients (PCH 07-079) Phase : Expanded Access Site: Phoenix Status: Open A Phase I Trial to Examine the Safety, Clinical, Immunologic and Virologic Effects of CMV pp65/IE-1 Specific Cytotoxic T Lymphocytes for Recipients of Allogeneic Stem Cell Transplants with Persistent or Therapy Refractory Infections (PCH 08-030) Phase : 1 Site: Phoenix Status: Open © 2009, Phoenix Children's Hospital.
|
|
Bone Marrow Transplant